← back to search

Esther Rose

Janssen (United States) · US
Area of research
Genetics · Hematology
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Hemoglobinopathies and Related Disorders, and Viral-associated cancers and disorders.
h-index
17
citations
1,687
works
32
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis
Journal of Clinical Oncology 2021cited by 103position: middledoi
Imetelstat Is Effective Treatment for Patients with Intermediate-2 or High-Risk Myelofibrosis Who Have Relapsed on or Are Refractory to Janus Kinase Inhibitor Therapy: Results of a Phase 2 Randomized Study of Two Dose Levels
Blood 2018cited by 34position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ronald Hoffman · Moffitt Cancer Center2 papers (2018–2021)Jean‐Jacques Kiladjian · Inserm2 papers (2018–2021)Rami S. Komrokji · Moffitt Cancer Center2 papers (2018–2021)Faye Feller · Geron (United States)2 papers (2018–2021)Maria R. Baer · University of Pennsylvania2 papers (2018–2021)Jacqueline Bussolari · Johnson & Johnson (United States)2 papers (2018–2021)Olatoyosi Odenike · Leipzig University2 papers (2018–2021)Fei Huang · Gilead Sciences (United States)2 papers (2018–2021)Laurie Sherman · GAF (United States)2 papers (2018–2021)John Mascarenhas · Incyte (United States)2 papers (2018–2021)Bart L. Scott · University of Florence2 papers (2018–2021)Souria Dougherty · Gilead Sciences (United States)2 papers (2018–2021)— · 2 papers (2018–2021)— · 2 papers (2018–2021)Alessandro M. Vannucchi · All India Institute of Medical Sciences1 papers (2021–2021)Michèle Cavo · Torino e-district1 papers (2018–2018)Ying Wan · Eon Corporation (United States)1 papers (2021–2021)Libo Sun · Stomatology Hospital1 papers (2021–2021)Aleksandra Rizo · Reckitt Benckiser (United States)1 papers (2021–2021)Francesca Palandri · Bristol-Myers Squibb (Switzerland)1 papers (2021–2021)